Dade Behring hsCRP license
This article was originally published in The Gray Sheet
Executive Summary
High-sensitivity C-reactive protein assay non-exclusive sublicense granted by Dade Behring will enable Ortho-Clinical Diagnostics to develop, manufacture and market its own hsCRP assay for cardiovascular risk assessment for use with its Vitros 5,1 FS system. The chemistry system uses the J&J unit's MicroTip technology to eliminate sample and reagent carryover, according to the firm...